ANAPHYLM Trademark
Trademark Overview
On Tuesday, November 26, 2024, a trademark application was filed for ANAPHYLM with the United States Patent and Trademark Office. The USPTO has given the ANAPHYLM trademark a serial number of 98873662. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, February 12, 2026. This trademark is owned by Aquestive Therapeutics, Inc.. The ANAPHYLM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations containing epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions
General Information
| Serial Number | 98873662 |
| Word Mark | ANAPHYLM |
| Filing Date | Tuesday, November 26, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, February 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 1, 2025 |
Trademark Statements
| Description of Mark | The mark consists of an incomplete, open rectangle, the top and left side of the rectangle appearing in the color blue, and the bottom and right side of the rectangle appearing in the color yellow, with the word "ANAPHYLM" in blue, going through the center. |
| Indication of Colors claimed | The color(s) blue and yellow is/are claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations containing epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Aquestive Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
| Party Name | Aquestive Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
Trademark Events
| Event Date | Event Description |
| Tuesday, November 26, 2024 | NEW APPLICATION ENTERED |
| Sunday, May 18, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, May 18, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, May 19, 2025 | ASSIGNED TO EXAMINER |
| Monday, May 19, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, May 19, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, May 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 27, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 25, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 1, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 1, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 26, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 12, 2026 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 12, 2026 | SOU EXTENSION 1 FILED |
| Thursday, February 12, 2026 | SOU EXTENSION 1 GRANTED |
| Thursday, February 12, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
